Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Multidisciplinary Approach to Alzheimer's Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment
Chiara Zucchella, Elena Sinforiani, Stefano Tamburin, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 246

Showing 1-25 of 246 citing articles:

Digitalization to achieve sustainable development goals: Steps towards a Smart Green Planet
María E. Mondéjar, Ram Avtar, Heyker Lellanis Baños Díaz, et al.
The Science of The Total Environment (2021) Vol. 794, pp. 148539-148539
Open Access | Times Cited: 590
Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
Zahinoor Ismail, Sandra E. Black, Richard Camicioli, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 8, pp. 1182-1195
Open Access | Times Cited: 182
The Effect of a Virtual Reality-Based Intervention Program on Cognition in Older Adults with Mild Cognitive Impairment: A Randomized Control Trial
Ngeemasara Thapa, Hye Jin Park, Ja‐Gyeong Yang, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1283-1283
Open Access | Times Cited: 167
Telemedicine and Virtual Reality for Cognitive Rehabilitation: A Roadmap for the COVID-19 Pandemic
Elisa Mantovani, Chiara Zucchella, Sara Bottiroli, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 139
Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives
Teresa Pardo-Moreno, Anabel González‐Acedo, Antonio Rivas-Domínguez, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1117-1117
Open Access | Times Cited: 128
Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
Rammohan V. Rao, Kaavya G. Subramaniam, Julie Gregory, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1659-1659
Open Access | Times Cited: 56
Voice quality and speech fluency distinguish individuals with Mild Cognitive Impairment from Healthy Controls
Charalambos Themistocleous, Marie Eckerström, Dimitrios Kokkinakis
PLoS ONE (2020) Vol. 15, Iss. 7, pp. e0236009-e0236009
Open Access | Times Cited: 82
The Muscle-Brain Axis and Neurodegenerative Diseases: The Key Role of Mitochondria in Exercise-Induced Neuroprotection
Johannes Burtscher, Grégoire P. Millet, Nicolas Place, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6479-6479
Open Access | Times Cited: 82
Machine Learning Algorithms and Statistical Approaches for Alzheimer’s Disease Analysis Based on Resting-State EEG Recordings: A Systematic Review
Katerina D. Tzimourta, Vasileios Christou, Alexandros T. Tzallas, et al.
International Journal of Neural Systems (2021) Vol. 31, Iss. 05, pp. 2130002-2130002
Closed Access | Times Cited: 66
Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease
Victoria García‐Morales, Anabel González‐Acedo, Lucia Melguizo‐Rodríguez, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1910-1910
Open Access | Times Cited: 57
Vascular Dementia and Underlying Sex Differences
Firoz Akhter, Alicia Persaud, Younis Zaokari, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 56
Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation
Javad Sharifi‐Rad, Simona Rapposelli, Simona Sestito, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1515-1515
Open Access | Times Cited: 45
Functionalised penetrating peptide-chondroitin sulphate‑gold nanoparticles: Synthesis, characterization, and applications as an anti-Alzheimer's disease drug
Yangjun Feng, Xiaolin Li, Dongsheng Ji, et al.
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123125-123125
Closed Access | Times Cited: 24
Symptoms and conventional treatments of Alzheimer's disease
Mehul R. Chorawala, Aayushi C. Shah, Aanshi J. Pandya, et al.
Elsevier eBooks (2024), pp. 213-234
Closed Access | Times Cited: 8
Socially Assistive Robots for patients with Alzheimer's Disease: A scoping review
Vania Karami, Mark J. Yaffe⃰, Geneviève Gore, et al.
Archives of Gerontology and Geriatrics (2024) Vol. 123, pp. 105409-105409
Open Access | Times Cited: 8
Comparison between physical and cognitive treatment in patients with MCI and Alzheimer’s disease
Cristina Fonte, Nicola Smania, Anna Pedrinolla, et al.
Aging (2019) Vol. 11, Iss. 10, pp. 3138-3155
Open Access | Times Cited: 69
Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease
Liaoyao Wang, Jian Pei, Yijun Zhan, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 63
Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients
А Н Боголепова, Е Е Васенина, N. A. Gomzyakova, et al.
S S Korsakov Journal of Neurology and Psychiatry (2021) Vol. 121, Iss. 10, pp. 6-6
Closed Access | Times Cited: 53
Phytotherapy: A promising approach for the treatment of Alzheimer's disease
Ogbodo Onyebuchi John, Ihim Stella Amarachi, Chinazom Precious Agbo, et al.
Pharmacological Research - Modern Chinese Medicine (2021) Vol. 2, pp. 100030-100030
Open Access | Times Cited: 45
Activities Recognition, Anomaly Detection and Next Activity Prediction Based on Neural Networks in Smart Homes
Khaled A. Alaghbari, Mohamad Hanif Md Saad, Aini Hussain, et al.
IEEE Access (2022) Vol. 10, pp. 28219-28232
Open Access | Times Cited: 36
Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives
Elisa Mantovani, Chiara Zucchella, Andreas A. Argyriou, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 1, pp. 25-43
Closed Access | Times Cited: 19
Enhancing cognitive flexibility and working memory in individuals with mild cognitive impairment: Exploring the impact of virtual reality on daily life activities
Mahdieh Sasaninezhad, Alireza Moradi, Sharareh Farahimanesh, et al.
Geriatric Nursing (2024) Vol. 56, pp. 32-39
Closed Access | Times Cited: 6
Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach
Damiana Scuteri, Laura Rombolà, Luigi Antonio Morrone, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3327-3327
Open Access | Times Cited: 50
Recommendations for the Nonpharmacological Treatment of Apathy in Brain Disorders
Valéria Manera, Sharon Abrahams, Luis Agüera‐Ortiz, et al.
American Journal of Geriatric Psychiatry (2019) Vol. 28, Iss. 4, pp. 410-420
Open Access | Times Cited: 50
Preventive and Therapeutic Potential of Physical Exercise in Neurodegenerative Diseases
Inês Marques‐Aleixo, Jorge Beleza, Arnaldina Sampaio, et al.
Antioxidants and Redox Signaling (2020) Vol. 34, Iss. 8, pp. 674-693
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top